These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Targeting the molecular pathophysiology of gastrointestinal stromal tumors with imatinib. Mechanisms, successes, and challenges to rational drug development. Demetri GD Hematol Oncol Clin North Am; 2002 Oct; 16(5):1115-24. PubMed ID: 12512386 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Miettinen M; El-Rifai W; H L Sobin L; Lasota J Hum Pathol; 2002 May; 33(5):478-83. PubMed ID: 12094372 [TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal stromal tumors (GIST): a model for molecule-based diagnosis and treatment of solid tumors. Kitamura Y; Hirota S; Nishida T Cancer Sci; 2003 Apr; 94(4):315-20. PubMed ID: 12824897 [TBL] [Abstract][Full Text] [Related]
13. The GIST of targeted cancer therapy: a tumor (gastrointestinal stromal tumor), a mutated gene (c-kit), and a molecular inhibitor (STI571). DeMatteo RP Ann Surg Oncol; 2002 Nov; 9(9):831-9. PubMed ID: 12417503 [TBL] [Abstract][Full Text] [Related]
14. The role of KIT in the management of patients with gastrointestinal stromal tumors. Hornick JL; Fletcher CD Hum Pathol; 2007 May; 38(5):679-87. PubMed ID: 17437861 [TBL] [Abstract][Full Text] [Related]
16. Is there a role for surgery in patients with "unresectable" cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate? Scaife CL; Hunt KK; Patel SR; Benjamin RS; Burgess MA; Chen LL; Trent J; Raymond AK; Cormier JN; Pisters PW; Pollock RE; Feig BW Am J Surg; 2003 Dec; 186(6):665-9. PubMed ID: 14672776 [TBL] [Abstract][Full Text] [Related]
17. Role of imatinib mesylate (Gleevec/Glivec) in gastrointestinal stromal tumors. de Jong FA; Verweij J Expert Rev Anticancer Ther; 2003 Dec; 3(6):757-66. PubMed ID: 14686698 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological Inhibition of KIT Activates MET Signaling in Gastrointestinal Stromal Tumors. Cohen NA; Zeng S; Seifert AM; Kim TS; Sorenson EC; Greer JB; Beckman MJ; Santamaria-Barria JA; Crawley MH; Green BL; Rossi F; Besmer P; Antonescu CR; DeMatteo RP Cancer Res; 2015 May; 75(10):2061-70. PubMed ID: 25836719 [TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal stromal tumors (GIST): C-kit mutations, CD117 expression, differential diagnosis and targeted cancer therapy with Imatinib. de Silva CM; Reid R Pathol Oncol Res; 2003; 9(1):13-9. PubMed ID: 12704441 [TBL] [Abstract][Full Text] [Related]
20. Management of gastrointestinal stromal tumors in the era of tyrosine kinase inhibitors. George S; Desai J Curr Treat Options Oncol; 2002 Dec; 3(6):489-96. PubMed ID: 12392638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]